{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:14:42Z","timestamp":1740107682377,"version":"3.37.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10067-016-3466-8","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T07:49:11Z","timestamp":1479887351000},"page":"831-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["APRIL gene polymorphism and serum sAPRIL levels in children with systemic lupus erythematosus"],"prefix":"10.1007","volume":"36","author":[{"given":"Shideh","family":"Namazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Ziaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Sadr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezou","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Zoghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"key":"3466_CR1","doi-asserted-by":"crossref","unstructured":"Pisetsky D.S. The immunopathogenesis and immunopathology of systemic lupus erythematosus. In: Schur P.H, Massarotti E.M. Lupus erythematosus: clinical evaluation and treatment. New York: Springer, 2012. 13\u201326.","DOI":"10.1007\/978-1-4614-1189-5_2"},{"key":"3466_CR2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cden.2013.06.003","volume":"57","author":"G Fortuna","year":"2013","unstructured":"Fortuna G, Brennan MT (2013) Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management. Dent Clin N Am 57:631\u2013655","journal-title":"Dent Clin N Am"},{"issue":"81","key":"3466_CR3","first-page":"85","volume":"15","author":"JE Lewis","year":"2013","unstructured":"Lewis JE, Man Fu S, Gaskin F (2013) Autoimmunity, end organ damage and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus. Discov Med 15(81):85\u201392","journal-title":"Discov Med"},{"key":"3466_CR4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.berh.2013.07.007","volume":"27","author":"C Malattia","year":"2013","unstructured":"Malattia C, Martini A (2013) Pediatric-onset systemic lupus erythematosus. Best Pract Res Cl Rh 27:351\u2013362","journal-title":"Best Pract Res Cl Rh"},{"key":"3466_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/584374","volume":"584374","author":"M Relle","year":"2012","unstructured":"Relle M, Schwarting A (2012) Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus. Clin Dev Immunol 584374:1\u201315","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"3466_CR6","first-page":"1","volume":"8","author":"N Tiffin","year":"2013","unstructured":"Tiffin N, Adeyemo A, Okpechi I (2013) A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus. Orphanet J Rare Dis 8(2):1\u20138","journal-title":"Orphanet J Rare Dis"},{"key":"3466_CR7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.trsl.2012.01.021","volume":"159","author":"A J.M","year":"2012","unstructured":"J.M A, Liu C, A.H K, Manzi S (2012) Biomarker for systemic lupus erythematosus. Transl Res 159:326\u2013342","journal-title":"Transl Res"},{"key":"3466_CR8","doi-asserted-by":"crossref","unstructured":"Connolly J.J, Hakonarson H. Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing. J Biomed Biotechnol 2012; 798924: 1\u201317.","DOI":"10.1155\/2012\/798924"},{"key":"3466_CR9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.188.6.1185","volume":"188","author":"M Hahne","year":"1998","unstructured":"Hahne M, Kataoka T, Schr\u00f6ter M, Hofmann K et al (1998) APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188:1185\u20131190","journal-title":"J Exp Med"},{"key":"3466_CR10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/embo-reports\/kve198","volume":"2","author":"M Lo\u2019pez-Fraga","year":"2001","unstructured":"Lo\u2019pez-Fraga M, Ferna\u2019ndez R, Albar JP, Hahne M (2001) Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep 2:945\u2013951","journal-title":"EMBO Rep"},{"key":"3466_CR11","first-page":"1021","volume":"60","author":"K Kelly","year":"2000","unstructured":"Kelly K, Manos E, Jensen G et al (2000) APRIL\/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res 60:1021\u20131027","journal-title":"Cancer Res"},{"key":"3466_CR12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","volume":"3","author":"MB Litinskiy","year":"2002","unstructured":"Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P et al (2002) DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3:822\u2013829","journal-title":"Nat Immunol"},{"key":"3466_CR13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0960-9822(00)00566-2","volume":"10","author":"SA Marsters","year":"2000","unstructured":"Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A (2000) Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 10:785\u2013788","journal-title":"Curr Biol"},{"key":"3466_CR14","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI0215034","volume":"109","author":"JV Stein","year":"2002","unstructured":"Stein JV, L\u00f3pez-Fraga M, Elustondo FA, Carvalho-Pinto CE et al (2002) APRIL modulates B and T cell immunity. J Clin Invest 109:1587\u20131598","journal-title":"J Clin Invest"},{"key":"3466_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd1982","volume":"5","author":"SR Dillon","year":"2006","unstructured":"Dillon SR, Gross JA, Ansell SM, Novak AJ (2006) An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5:235\u2013246","journal-title":"Nat Rev Drug Discov"},{"key":"3466_CR16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/79802","volume":"1","author":"G Yu","year":"2000","unstructured":"Yu G, Boone T, Delaney J et al (2000) APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol 1:252\u2013256","journal-title":"Nat Immunol"},{"key":"3466_CR17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20042309","volume":"201","author":"K Ingold","year":"2005","unstructured":"Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner QG, Cachero TG et al (2005) Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 201:1375\u20131383","journal-title":"J Exp Med"},{"key":"3466_CR18","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1182\/blood-2006-08-041772","volume":"109","author":"D Sakurai","year":"2007","unstructured":"Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K (2007) Kobata T.TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 109:2961\u20132967","journal-title":"Blood"},{"key":"3466_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0609.2009.01262.x","volume":"83","author":"J Moreaux","year":"2009","unstructured":"Moreaux J, Sprynski AC, Dillon SR, Mahtouk K et al (2009) APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop. Eur J Haematol 83:119\u2013129","journal-title":"Eur J Haematol"},{"key":"3466_CR20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/rheumatology\/keg270","volume":"42","author":"T Koyama","year":"2003","unstructured":"Koyama T, Tsukamoto H, Masumoto K, Himeji D, Hayashi K, Harada M et al (2003) A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheumatology 42:980\u2013985","journal-title":"Rheumatology"},{"key":"3466_CR21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.cdd.4401647","volume":"12","author":"J Handriks","year":"2005","unstructured":"Handriks J, Planelles L, de Jong-Odding J et al (2005) Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 12:637\u2013648","journal-title":"Cell Death Differ"},{"key":"3466_CR22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/rheumatology\/kem019","volume":"46","author":"A Kawasaki","year":"2007","unstructured":"Kawasaki A, Tsuchiya N, Ohashi J et al (2007) Role of APRIL (TNFSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese. Rheumatology 46:776\u2013782","journal-title":"Rheumatology"},{"key":"3466_CR23","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/rheumatology\/kem093","volume":"46","author":"YH Lee","year":"2007","unstructured":"Lee YH, Ota F, Kim-Howard X, Kaufman KM, Nath SK (2007) APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility. Rheumatology 46:1274\u20131276","journal-title":"Rheumatology"},{"key":"3466_CR24","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2004.022491","volume":"64","author":"T Koyama","year":"2005","unstructured":"Koyama T, Tsukamoto H, Miyagi Y et al (2005) Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis 64:1065\u20131067","journal-title":"Ann Rheum Dis"},{"key":"3466_CR25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/ard.2008.090928","volume":"68","author":"J Morel","year":"2009","unstructured":"Morel J, Roubille C, Planelles L et al (2009) Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus. Ann Rheum Dis 68:997\u20131002","journal-title":"Ann Rheum Dis"},{"key":"3466_CR26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clim.2009.12.012","volume":"135","author":"M Hegazy","year":"2010","unstructured":"Hegazy M, Darwish H, Darweesh H, El-Shehaby A, Emad Y (2010) Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices. Clin Immunol 135:118\u2013124","journal-title":"Clin Immunol"},{"issue":"2","key":"3466_CR27","doi-asserted-by":"crossref","first-page":"e31837","DOI":"10.1371\/journal.pone.0031837","volume":"7","author":"B Huard","year":"2012","unstructured":"Huard B, Lan Tran N, Benkhoucha M, Manzin-Lorenzi C, Santiago-Raber M (2012) Selective APRIL blockade delays systemic lupus erythematosus in mouse. PLoS One 7(2):e31837","journal-title":"PLoS One"},{"issue":"R167","key":"3466_CR28","first-page":"1","volume":"8","author":"T Vallerskog","year":"2006","unstructured":"Vallerskog T, Heimb\u00fcrger M, Gunnarsson I, Zhou W, Wahren-Herlenius M, Trollmo C, Malmstrom V (2006) Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 8(R167):1\u201310","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3466_CR29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/08916934.2010.545846","volume":"44","author":"K Minowa","year":"2011","unstructured":"Minowa K, Amano H, Nakano S, Ando S, Watanabe T, Nakiri Y, Amano E, Tokano Y, Morimoto S, Takasaki Y (2011) Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus. Autoimmunity 44(5):357\u2013362","journal-title":"Autoimmunity"},{"key":"3466_CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/nep.12032","volume":"18","author":"G Xin","year":"2013","unstructured":"Xin G, Cui Z, Su Y, Xu L, Zhao M, Li K (2013) Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease. Nephrology 18:209\u2013214","journal-title":"Nephrology"},{"key":"3466_CR31","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/rheumatology\/kes080","volume":"51","author":"V J.L","year":"2012","unstructured":"J.L V, Roescher N, Polling EJ, Illei GG, Tak PP (2012) The expression of APRIL in Sj\u00f6gren\u2019s syndrome: aberrant expression of APRIL in the salivary gland. Rheumatology 51:1557\u20131562","journal-title":"Rheumatology"},{"key":"3466_CR32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-0625.2007.00642.x","volume":"17","author":"T Matsushita","year":"2008","unstructured":"Matsushita T, Fujimoto M, Echigo T et al (2008) Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis. Exp Dermatol 17:197\u2013202","journal-title":"Exp Dermatol"},{"key":"3466_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1097-4644(19960101)60:1<47::AID-JCB8>3.0.CO;2-3","volume":"60","author":"W C.F","year":"1996","unstructured":"C.F W, VanArsdale S, VanArsdale TL (1996) Apoptosis mediated by the TNF-related cytokine and receptor families. J Cell Biochem 60:47\u201355","journal-title":"J Cell Biochem"},{"key":"3466_CR34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673\u2013682","journal-title":"Immunity"},{"key":"3466_CR35","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","volume":"271","author":"RM Pitti","year":"1996","unstructured":"Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687\u201312690","journal-title":"J Biol Chem"},{"key":"3466_CR36","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","volume":"272","author":"BR Wong","year":"1997","unstructured":"Wong BR, Rho J, Arron J et al (1997) TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272:25190\u201325194","journal-title":"J Biol Chem"},{"key":"3466_CR37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson DM, Maraskovsky E, Billingsley WL et al (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function. Nature (Lond) 390:175\u2013179","journal-title":"Nature (Lond)"},{"key":"3466_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-7613(00)80455-0","volume":"8","author":"M D.N","year":"1998","unstructured":"D.N M, Ebner R, Montgomery RI et al (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin a are ligands for herpes virus entry mediator. Immunity 8:21\u201330","journal-title":"Immunity"},{"key":"3466_CR39","doi-asserted-by":"crossref","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","volume":"272","author":"Y Chicheportiche","year":"1997","unstructured":"Chicheportiche Y, Bourdon PR, Xu H et al (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272:32401\u201332410","journal-title":"J Biol Chem"},{"key":"3466_CR40","first-page":"956","volume":"76","author":"CA Smith","year":"1994","unstructured":"Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:956\u2013962","journal-title":"Cell"},{"key":"3466_CR41","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","volume":"189","author":"P Schneider","year":"1999","unstructured":"Schneider P, Mackay F, Steiner V et al (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189:1747\u20131756","journal-title":"J Exp Med"},{"key":"3466_CR42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","volume":"285","author":"PA Moore","year":"1999","unstructured":"Moore PA, Belvedere O, Orr A et al (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260\u2013263","journal-title":"Science"},{"key":"3466_CR43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.04007.x","volume":"158","author":"I Moisini","year":"2009","unstructured":"Moisini I, Davidson A (2009) BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 158:155\u2013163","journal-title":"Clin Exp Immunol"},{"key":"3466_CR44","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.molimm.2004.06.041","volume":"42","author":"LG Ng","year":"2005","unstructured":"Ng LG, Mackay CR, Mackay F (2005) The BAFF\/APRIL system: life beyond B lymphocytes. Mol Immunol 42:763\u2013772","journal-title":"Mol Immunol"},{"issue":"13","key":"3466_CR45","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1177\/0961203310375268","volume":"19","author":"LD Zhao","year":"2010","unstructured":"Zhao LD, Li Y, Smith MF Jr et al (2010) Expressions of BAFF\/BAFF receptors and their correlation with disease activity in Chinese SLE patients. Lupus 19(13):1534\u20131549","journal-title":"Lupus"},{"issue":"3","key":"3466_CR46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","volume":"24","author":"FB Vincent","year":"2013","unstructured":"Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F (2013) The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev 24(3):203\u2013215","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"3466_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2010.02470.x","volume":"73","author":"GA Lied","year":"2011","unstructured":"Lied GA, Berstad A (2011) Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. Scand J Immunol 73(1):1\u20137","journal-title":"Scand J Immunol"},{"issue":"3","key":"3466_CR48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/08916934.2011.637531","volume":"45","author":"A Castellanos-Rubio","year":"2012","unstructured":"Castellanos-Rubio A, Caja S, Irastorza I et al (2012) Angiogenesis-related gene expression analysis in celiac disease. Autoimmunity 45(3):264\u2013270","journal-title":"Autoimmunity"},{"issue":"10","key":"3466_CR49","doi-asserted-by":"crossref","first-page":"e47990","DOI":"10.1371\/journal.pone.0047990","volume":"7","author":"M Yang","year":"2012","unstructured":"Yang M, Wu Y, Lu Y et al (2012) Genome-wide scan identifies variant in TNFSF13 associated with serum IgM in a healthy Chinese male population. PLoS One 7(10):e47990","journal-title":"PLoS One"},{"issue":"4","key":"3466_CR50","doi-asserted-by":"crossref","first-page":"e32683","DOI":"10.1371\/journal.pone.0032683","volume":"7","author":"W Osman","year":"2012","unstructured":"Osman W, Okada Y, Kamatani Y, Kubo M, Matsuda K, Nakamura Y (2012) Association of common variants in TNFRSF13B, TNFSF13, and ANXA3 with serum levels of non-albumin protein and immunoglobulin isotypes in Japanese. PLoS One 7(4):e32683","journal-title":"PLoS One"},{"key":"3466_CR51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2172-9-3","volume":"9","author":"U Salzer","year":"2008","unstructured":"Salzer U, Neumann C, Thiel J et al (2008) Screening of functional and positional candidate genes in families with common variable immunodeficiency. BMC Immunol 9:3","journal-title":"BMC Immunol"},{"key":"3466_CR52","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.autrev.2012.03.004","volume":"11","author":"V Sau-Fong Chan","year":"2012","unstructured":"Sau-Fong Chan V, Nie YJ, Shen N, Yan S, Mok MY, Lau CS (2012) Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmunity Rev 11:890\u2013897","journal-title":"Autoimmunity Rev"},{"key":"3466_CR53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/s10165-011-0539-z","volume":"22","author":"T Furuya","year":"2012","unstructured":"Furuya T, Koga M, Hikami K, Kawasaki A, Tsuchiya N (2012) Effects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL. Mod Rheumatol 22:541\u2013549","journal-title":"Mod Rheumatol"},{"key":"3466_CR54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1684\/ecn.2014.0352","volume":"25","author":"V Ziaee","year":"2014","unstructured":"Ziaee V, Tahghighi F, Moradinejad MH et al (2014) Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 25:35\u201340","journal-title":"Eur Cytokine Netw"},{"key":"3466_CR55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/08916934.2015.1101071","volume":"49","author":"A Hammad","year":"2016","unstructured":"Hammad A, Mosaad YM, Hammad EM et al (2016) Interleukin-17A rs2275913, interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in juvenile lupus and lupus related nephritis. Autoimmunity 49:31\u201340","journal-title":"Autoimmunity"},{"key":"3466_CR56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cei.12666","volume":"182","author":"YM Mosaad","year":"2015","unstructured":"Mosaad YM, Hammad A, Fawzy Z et al (2015) C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis. Clin Exp Immunol 182:23\u201334","journal-title":"Clin Exp Immunol"},{"key":"3466_CR57","first-page":"769","volume":"38","author":"M Yanagimachi","year":"2011","unstructured":"Yanagimachi M, Naruto T, Miyamae T et al (2011) Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. Rheumatol 38:769\u2013774","journal-title":"Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3466-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T12:59:35Z","timestamp":1601211575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3466-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3466"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3466-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2016,11,23]]}}}